Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
A Non-Drug Study of The Suitability of Neurocognitive Tests And Functioning Scales For The Measurement of Cognitive And Functioning Changes in Individuals With Down Syndrome
OBSERVATIONAL
Inicio: 1 de feb de 2012
ID: NCT01580384
Completado
Fase 3
ClinicalTrials.gov
A Study to Compare Long-Term Safety and Tolerability of Stavudine (d4T) Extended Release (ER) Versus Conventional (Immediate Release, IR) Formulations, Each In Combination With Lamivudine (3TC) and Efavirenz (EFV) in Subjects Who Have Completed BMS Studies AI455-096 and AI455-099
INTERVENTIONAL
Inicio: 1 de ene de 2001
ID: NCT00116298
Completado
Fase 2
ClinicalTrials.gov
A 3-Month, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Safety, Tolerability, and Efficacy Study Of 3 Doses Of Lecozotan (SRA-333) SR In Outpatients With Mild To Moderate Alzheimer's Disease With Donepezil As Active Control.
INTERVENTIONAL
Inicio: 6 de oct de 2005
ID: NCT00151398
Terminado
Fase 3
ClinicalTrials.gov
EPIK-O: A Phase III, Multi-center, Randomized (1:1), Open-label, Active-controlled, Study to Assess the Efficacy and Safety of Alpelisib (BYL719) in Combination With Olaparib as Compared to Single Agent Cytotoxic Chemotherapy, in Participants With no Germline BRCA Mutation Detected, Platinum-resistant or Refractory, High-grade Serous Ovarian Cancer
INTERVENTIONAL
Inicio: 22 de jul de 2021
ID: NCT04729387
Completado
ClinicalTrials.gov
Effect of a Home-based Versus Supervised Exercise Program in Patients With Migraine: a Randomized Clinical Trial
INTERVENTIONAL
Inicio: 13 de jun de 2022
ID: NCT05292599
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects With Epilepsy ≥4 Years to <17 Years of Age With Partial Onset Seizures
INTERVENTIONAL
Inicio: 29 de ago de 2013
ID: NCT01921205
Reclutando
Fase 3
ClinicalTrials.gov
Lateral Cord Magnetic Stimulation For Refractory Spastic Cerebral Palsy - Multicenter Double Blind Randomized and Controlled Trial
INTERVENTIONAL
Inicio: 18 de nov de 2024
ID: NCT03676439
Completado
Fase 3
ClinicalTrials.gov
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
INTERVENTIONAL
Inicio: 15 de dic de 2015
ID: NCT02549170
Completado
Fase 2
ClinicalTrials.gov
A Phase II, Single Arm, Open Label Study of Treatment-free Remission in Chronic Myeloid Leukemia (CML) Chronic Phase (CP) Patients After Achieving Sustained MR4.5 on Nilotinib
INTERVENTIONAL
Inicio: 20 de dic de 2012
ID: NCT01698905
Completado
ClinicalTrials.gov
Cardiovascular Registry of Atrial Fibrillation in Latin America: The LACROSS Study
OBSERVATIONAL
Inicio: 4 de ago de 2020
ID: NCT04456842
Reclutando
ClinicalTrials.gov
Baseline Ventilatory Parameters in Patients With Acute Neurological Injury
OBSERVATIONAL
Inicio: 1 de may de 2024
ID: NCT06192342
Completado
Fase 3
ClinicalTrials.gov
A Randomized Controlled Trial of Rivaroxaban for the Prevention of Major Cardiovascular Events in Patients With Coronary or Peripheral Artery Disease (COMPASS - Cardiovascular OutcoMes for People Using Anticoagulation StrategieS).
INTERVENTIONAL
Inicio: 28 de feb de 2013
ID: NCT01776424
Completado
ClinicalTrials.gov
Observational Study to Assess the Quality of Life of the Caregivers of Patients With Multiple Sclerosis
OBSERVATIONAL
Inicio: 1 de ago de 2008
ID: NCT01075737
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
INTERVENTIONAL
Inicio: 1 de oct de 2004
ID: NCT00113165
Completado
Fase 3
ClinicalTrials.gov
An Open-Label Extension Phase of the Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Studies to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
INTERVENTIONAL
Inicio: 1 de oct de 2008
ID: NCT00735397
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2a/2b Randomized, Placebo-Controlled Clinical Study To Evaluate The Safety And Efficacy Of MK-1942 As Adjunctive Therapy In Participants With Mild To Moderate Alzheimer's Disease Dementia
INTERVENTIONAL
Inicio: 2 de dic de 2022
ID: NCT05602727
Reclutando
ClinicalTrials.gov
Clinical Trial in Hypertensive Patients Comparing Two Cardiorespiratory Exercise Protocols, Low-volume Sprint Interval Training (SIT) Versus Moderate-intensity Continuous Training (MICT), to Evaluate Decreases in Ambulatory Blood Pressure and Other Clinical Variables.
INTERVENTIONAL
Inicio: 29 de abr de 2025
ID: NCT07229196
Desconocido
Fase 1 temprana
ClinicalTrials.gov
Psychosocial Group Intervention to Enhance Empowerment of People With Dementia and Their Caregivers: Study Protocol for a Randomized Controlled Trial
INTERVENTIONAL
Inicio: 1 de sept de 2014
ID: NCT02391766
Activo, no recluta
Fase 4
ClinicalTrials.gov
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
INTERVENTIONAL
Inicio: 20 de sept de 2019
ID: NCT03950076
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy And Safety Trial Of Bapineuzumab (Aab-001, Eln115727) In Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E 4 Non-carriers
INTERVENTIONAL
Inicio: 1 de jun de 2008
ID: NCT00667810
Anterior
1
...
27
28
29
...
434
Siguiente
Filtros